Home  Contact Us
  Follow Us On:
 
Search:
Advertising Advertising Free Newsletter Free E-Newsletter
NEWS

WHO halts hydroxychloroquine trial for coronavirus
Published on: 2020-05-26
Share to
User Rating: / 0
PoorBest 

DRUGThe World Health Organization has temporarily halted studying hydroxychloroquine as a potential Covid-19 treatment due to safety concerns, WHO Director-General Tedros Adhanom Ghebreyesus said during a media briefing in Geneva on Monday.
 

The decision was made after an observational study published Friday in the medical journal The Lancet described how seriously ill Covid-19 patients who were treated with hydroxychloroquine and chloroquine were more likely to die. Tedros said that an independent executive group is now reviewing the use of hydroxychloroquine in WHO's Solidarity Trial. The executive group represents 10 of the participating countries in the trial.
 

"The review will consider data collected so far in the Solidarity Trial and, in particular robust randomized available data, to adequately evaluate the potential benefits and harms from this drug," Tedros said. "The Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the data is reviewed by the Data Safety Monitoring Board."
 

"This concern relates to the use of hydroxychloroquine and chloroquine in Covid-19," he said. "I wish to reiterate that these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria."
 

Dr. Soumya Swaminathan, WHO chief scientist, said Monday the trial has only been using hydroxychloroquine, not the more toxic chloroquine.

DRUG 2President Donald Trump claimed on May 18 that he was taking daily doses of hydroxychloroquine.
 

Members of the National Guard communicate with individuals at a newly opened Coronavirus testing site in Brooklyn on April 11
 

Trump said he has taken the antimalarial drug after consulting the White House doctor, though stopped short of saying his physician had actually recommended the drug.
 

Trump said he hadn't been exposed to coronavirus, and he started taking the drug because he had heard from frontline responders who sent him letters saying they were taking it preventatively.
 

Trump's comments about hydroxychloroquine have led to the soaring sales of the drug.
 

特朗普曾吃了一周的“神药” 被世卫组织暂停临床试验了

当地时间25日,世卫组织(WHO)宣布,出于安全考虑,世卫组织已暂停使用抗疟疾药物羟氯喹治疗新冠肺炎患者的临床试验。上周美国总统特朗普声称,他服用羟氯喹超过一周时间,用来预防新冠肺炎。
 

谭德塞表示,这项决定是在医学期刊《柳叶刀》公布一项研究后做出的。该研究表明,使用含有羟氯喹或氯喹对于新冠病毒感染患者的治疗无益处,反而会增加室性心律失常和院内死亡的危险。不过谭德塞补充,关于瑞德西韦等药物的研究仍在进行中。
 

上周美国总统特朗普声称,他服用羟氯喹超过一周时间,用来预防新冠肺炎。他于5月24日透露自己已停止服药,“顺便说一句,我还活着。”他还声称,羟氯喹“好评如潮”,挽救了许多生命。他19日接受采访时也曾自辩称,那些说药危险的研究都是“假研究”。

世界卫生组织此前建议,除非作为临床试验的一部分,否则不要使用羟基氯喹来治疗或预防新冠病毒感染。4月24日,美国食品药品监督管理局曾警告,除了住院或临床试验,不要用羟氯喹或氯喹治疗新冠肺炎,因为可能会导致心律失常。

Comments (0)Add Comment

Write comment

security code
Write the displayed characters


busy
    Subscription    |     Advertising    |     Contact Us    |
Address: Magnetic Plaza, Building A4, 6th Floor, Binshui Xi Dao.
Nankai District. 300381 TIANJIN. PR CHINA
Tel: +86 22 23917700
E-mail: webmaster@businesstianjin.com
Copyright 2020 BusinessTianjin.com. All rights reserved.